CIK 0001211583 · Non-accelerated filer<br>Smaller reporting company
FENNEC PHARMACEUTICALS INC.
Sign in to watch- Ticker
- FENC
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- British Columbia, Canada
- Entity type
- operating
- Phone
- (919) 636-4530
- Business address
- PO BOX 13628, 68 TW ALEXANDER DRIVE, RESEARCH TRIANGLE PARK, NC, 27709
- Former names
- ADHEREX TECHNOLOGIES INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,310,718
- in 4 filings, $1.2M under 10b5-1 plans
Net −$1,310,718. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-06-30 | Cioffi Christiana Marie Chief Strategy Officer | Grant or award | +156 | 24,332 | ||
| 2026-06-30 | Sayad Pierre Sargis Chief Medical Officer | Grant or award | +168 | 21,183 | ||
| 2026-06-30 | Evans Terry L Chief Commercial Officer | Grant or award | +168 | 21,183 | ||
| 2026-06-30 | Hackman Jeffrey S. Chief Executive Officer | Grant or award | +1,159 | 63,984 | ||
| 2026-06-30 | Andrade Robert CHIEF FINANCIAL OFFICER | Grant or award | +1,703 | 290,972 | ||
| 2026-06-10 | Cook Jodi A Director | Grant or award · Stock Options | +20,000 | $8.70 | $174K | 160,000 |
| 2026-06-10 | Islam Khalid Director | Grant or award · Stock Option | +25,000 | $8.70 | $218K | 250,000 |
| 2026-06-10 | Brughera Marco Maria Director | Grant or award · Stock Option | +20,000 | $8.70 | $174K | 235,545 |
| 2026-06-10 | RALLIS CHRIS A Director | Grant or award · Stock Option | +20,000 | $8.70 | $174K | 200,000 |
| 2026-06-01 | Raykov Rosty Director | Option exercise 10b5-1 | +15,597 | $2.45 | $38K | 139,826 |
| 2026-06-01 | Raykov Rosty Director | Sale 10b5-1 | −9,747 | $9.62 | $94K | 130,079 |
| 2026-06-01 | Raykov Rosty Director | Option exercise · Stock Options 10b5-1 | −15,597 | $2.45 | $38K | 1,556,195 |
| 2026-05-31 | Raykov Rosty Director | Grant or award 10b5-1 | +2,778 | 124,229 | ||
| 2026-05-31 | Cioffi Christiana Marie Chief Strategy Officer | Grant or award | +156 | 24,176 | ||
| 2026-05-31 | Sayad Pierre Sargis Chief Medical Officer | Grant or award | +168 | 21,015 | ||
| 2026-05-31 | Evans Terry L Chief Commercial Officer | Grant or award | +168 | 21,015 | ||
| 2026-05-31 | Hackman Jeffrey S. Chief Executive Officer | Grant or award | +1,159 | 62,825 | ||
| 2026-05-31 | Andrade Robert CHIEF FINANCIAL OFFICER | Grant or award | +1,703 | 289,269 | ||
| 2026-05-11 | RALLIS CHRIS A Director | Option exercise 10b5-1 | +14,344 | $2.44 | $35K | 71,423 |
| 2026-05-11 | RALLIS CHRIS A Director | Sale 10b5-1 | −8,346 | $7.04 | $59K | 63,077 |
Page 3 of 8 · 159 trades